SAFER Study Coordinator
Andrew completed an undergraduate degree in Sports and Exercise Sciences at the University of Wales, Bangor. Following that he worked as a Physical Activity Research Assistant with the MRC Epidemiology Unit in Cambridge. Here, Andrew met volunteers and took them through informed consent and a variety of measurements including anthropometric measurements, DEXA scans, ultrasound scans and a range of physical activity tests. Andrew then moved into study coordination with the MRC Epidemiology Unit learning the operational aspects of research and has worked on several studies including observational, natural intervention trials and clinical trials.
Andrew has also worked for the NIHR Cambridge BioResource leading the volunteer recruitment team, looking for strategies to increase the number of volunteers to the research panel. There, he also organised several large events for some of the panel to attend and hear about the research that the NIHR BioResource had conducted.
Andrew is now working as a study coordinator cardiovascular group within the Primary Care Unit. They are testing the effectiveness and cost effectiveness of implementing a screening programme in GP surgeries for atrial fibrillation (AF) as a measure for preventing strokes, heart attacks and other cardiovascular events.
Andrew has a keen interest in the responsibilities of study coordination especially in health research.
Ogilvie D, Panter J, Guell C, Jones A, Mackett R, Griffin S (2016). Health impacts of the Cambridgeshire Guided Busway: a natural experimental study. Public Health Research Volume: 4 Issue: 1, January 2016.
Forouhi NG, Menon RK, Sharp SJ, Mannan N, Timms PM, Martineau AR, Rickard AP, Boucher BJ, Chowdhury TA, Griffiths CJ, Greenwald SE, Griffin SJ and Hitman GA (2015). Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial. Diabetes, Obesity and Metabolism, volume 18: issue 4, December 2015.
Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, Davies M, Dymond A, Eichenberger R, Evans P, Gray A, Greaves C, Harrington K, Hitman G, Irving G, Lessels S, Millward A, Petrie JR, Rutter M, Sampson M, Sattar N and Sharp S (2018). Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Health Technology Assessment 2018;22:1-64. Published:Apr-2018.